Insight Enterprise Value Over E B I T D A from 2010 to 2026
| IMDX Stock | 6.57 0.05 0.77% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (0.40) | Current Value (0.42) | Quarterly Volatility 10.23823597 |
Check Insight Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insight Molecular's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Selling General Administrative of 11.5 M or Other Operating Expenses of 76 M, as well as many indicators such as Price To Sales Ratio of 18.07, Dividend Yield of 0.0015 or Days Sales Outstanding of 239. Insight financial statements analysis is a perfect complement when working with Insight Molecular Valuation or Volatility modules.
Insight | Enterprise Value Over E B I T D A | Build AI portfolio with Insight Stock |
Latest Insight Molecular's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Insight Molecular Diagnostics over the last few years. It is Insight Molecular's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insight Molecular's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Insight Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (9.70) | |
| Coefficient Of Variation | (105.58) | |
| Mean Deviation | 8.25 | |
| Median | (5.17) | |
| Standard Deviation | 10.24 | |
| Sample Variance | 104.82 | |
| Range | 38.3339 | |
| R-Value | 0.78 | |
| Mean Square Error | 44.34 | |
| R-Squared | 0.60 | |
| Significance | 0.0002 | |
| Slope | 1.57 | |
| Total Sum of Squares | 1,677 |
Insight Enterprise Value Over E B I T D A History
About Insight Molecular Financial Statements
Insight Molecular investors use historical fundamental indicators, such as Insight Molecular's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Insight Molecular. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (0.40) | (0.42) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| HITI | High Tide | |
| HITI | High Tide | |
| BAC | Bank of America |
Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.